Accéder au contenu
Merck

Catalytic mechanism of heparinase II investigated by site-directed mutagenesis and the crystal structure with its substrate.

The Journal of biological chemistry (2010-04-21)
David Shaya, Wenjing Zhao, Marie-Line Garron, Zhongping Xiao, Qizhi Cui, Zhenqing Zhang, Traian Sulea, Robert J Linhardt, Miroslaw Cygler
RÉSUMÉ

Heparinase II (HepII) is an 85-kDa dimeric enzyme that depolymerizes both heparin and heparan sulfate glycosaminoglycans through a beta-elimination mechanism. Recently, we determined the crystal structure of HepII from Pedobacter heparinus (previously known as Flavobacterium heparinum) in complex with a heparin disaccharide product, and identified the location of its active site. Here we present the structure of HepII complexed with a heparan sulfate disaccharide product, proving that the same binding/active site is responsible for the degradation of both uronic acid epimers containing substrates. The key enzymatic step involves removal of a proton from the C5 carbon (a chiral center) of the uronic acid, posing a topological challenge to abstract the proton from either side of the ring in a single active site. We have identified three potential active site residues equidistant from C5 and located on both sides of the uronate product and determined their role in catalysis using a set of defined tetrasaccharide substrates. HepII H202A/Y257A mutant lost activity for both substrates and we determined its crystal structure complexed with a heparan sulfate-derived tetrasaccharide. Based on kinetic characterization of various mutants and the structure of the enzyme-substrate complex we propose residues participating in catalysis and their specific roles.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Heparinase II from Flavobacterium heparinum, Lyophilized powder stabilized with approx. 25% bovine serum albumin, lyophilized powder, ≥100 units/mg protein (enzyme + BSA)